Literature DB >> 30802843

Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy.

Hai-Jiao Wang1, Ge Tan2, Li-Na Zhu3, Deng Chen4, Da Xu5, Shan-Shan Chu6, Ling Liu7.   

Abstract

PURPOSE: To evaluate the predictors of seizure reduction outcome after vagus nerve stimulation (VNS) in patients with drug-resistant epilepsy (DRE).
METHODS: A meta-analysis was performed using relevant research from databases such as PubMed, Embase, Cochrane Online Library, and Clinicaltrials.gov. Studies were selected according to predefined inclusion and exclusion criteria. The quality of studies was evaluated by using the Newcastle-Ottawa Scale (NOS) scale. All data was pooled by STATA 12.0 software for meta-analysis.
RESULTS: The review considered 1281 articles, and 16 articles with NOS score ≥6 were included in the analysis. The meta-analysis showed that at 6 m, 1, 2, 3, 4, 6 and 12 years after implantation, 33.99, 43.42, 46.50, 63.31, 52.71, 54.64, 70.37 and 82.90% of patients exhibited >50% reduction of seizure frequency after VNS. The duration of epilepsy showed a significant difference between the good responders and poor responders (p = 0.038), whereas age at VNS implantation (p = 0.305), age at seizure onset (p = 0.530), seizure type (p = 0.11), etiology (p = 0.187), and history of previous epilepsy surgery (p = 0.075) were not predictors of seizure reduction outcome after VNS. Several features about the electroencephalogram (EEG) feature and heart rhythm complexity (HRV) have not been analyzed by a sufficient number of studies.
CONCLUSIONS: DRE patients with shorter duration of epilepsy may be better candidates for VNS rather than those who are younger at onset and implantation. Several EEG or HRV features may have predictive value but more research is needed.
Copyright © 2019 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug-resistant; Epilepsy; pRedictor; vagus nerve stimulation

Mesh:

Year:  2019        PMID: 30802843     DOI: 10.1016/j.seizure.2019.02.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  5 in total

1.  Vagus nerve stimulation: a 20-year Australian experience.

Authors:  Charles F Yates; Kate Riney; Stephen Malone; Ubaid Shah; Liam G Coulthard; Robert Campbell; Geoff Wallace; Martin Wood
Journal:  Acta Neurochir (Wien)       Date:  2021-11-10       Impact factor: 2.216

Review 2.  Electroencephalogram and heart rate variability features as predictors of responsiveness to vagus nerve stimulation in patients with epilepsy: a systematic review.

Authors:  Sarosh Irfan Madhani; Mehdi Abbasi; Yang Liu; Jorge Arturo Larco; Evan Nicolai; Gregory Worrell; Luis Savastano
Journal:  Childs Nerv Syst       Date:  2022-09-22       Impact factor: 1.532

3.  Vagus nerve stimulation in children with drug-resistant epilepsy of monogenic etiology.

Authors:  Han Xie; Jiayi Ma; Taoyun Ji; Qingzhu Liu; Lixin Cai; Ye Wu
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

4.  A prediction model integrating synchronization biomarkers and clinical features to identify responders to vagus nerve stimulation among pediatric patients with drug-resistant epilepsy.

Authors:  Jiayi Ma; Zhiyan Wang; Tungyang Cheng; Yingbing Hu; Xiaoya Qin; Wen Wang; Guojing Yu; Qingzhu Liu; Taoyun Ji; Han Xie; Daqi Zha; Shuang Wang; Zhixian Yang; Xiaoyan Liu; Lixin Cai; Yuwu Jiang; Hongwei Hao; Jing Wang; Luming Li; Ye Wu
Journal:  CNS Neurosci Ther       Date:  2022-07-27       Impact factor: 7.035

Review 5.  Health Technology Assessment Report on Vagus Nerve Stimulation in Drug-Resistant Epilepsy.

Authors:  Carlo Efisio Marras; Gabriella Colicchio; Luca De Palma; Alessandro De Benedictis; Giancarlo Di Gennaro; Marilou Cavaliere; Elisabetta Cesaroni; Alessandro Consales; Sofia Asioli; Massimo Caulo; Flavio Villani; Nelia Zamponi
Journal:  Int J Environ Res Public Health       Date:  2020-08-24       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.